Cribriform breast cancer is a rare “special type” of invasive breast cancer. It gets its name from the way the cancer cells look under the microscope: they form neat rows and small, sieve-like openings, and pathologists use the word cribriform — from the Latin for “perforated like a sieve” — to describe that pattern. It is uncommon enough that many people never hear the name until it appears on their own pathology report, and this article explains what the term means, why it is mentioned, and what questions it is reasonable to bring back to your care team.
Key Takeaways
- Cribriform breast cancer is a rare special type of invasive breast cancer, named for the sieve-like pattern of the cells under the microscope.
- It is usually described as low-grade, meaning the cells look relatively similar to normal cells — but grading is only one part of the picture.
- Treatment is not decided by the name alone; your care team considers size, grade, spread, and other findings in your individual case.
- Because it is uncommon, asking your team to explain how they are using this finding in your plan is entirely reasonable.
- For figures that change over time, check the American Cancer Society (cancer.org) and the National Cancer Institute (cancer.gov).
- Every case is different. Talk to your own doctor or care team about what this finding means for you.
What the Word “Cribriform” Means
When a pathologist examines breast cancer tissue under a microscope, they look at the architecture of the cells — how the cells arrange themselves, how they resemble (or differ from) normal breast tissue, and what shapes they form. In cribriform breast cancer, the cancer cells grow in solid nests or sheets pierced by small, round, evenly spaced openings, like a sieve or a slice of Swiss cheese. That pattern is what the word “cribriform” describes.
This is a description of appearance, not a statement about behaviour. The name tells you what the pathologist saw; what the cancer will do in an individual person is a separate question, answered by combining this finding with size, grade, lymph node findings, and other results.
The word can appear in two contexts. Sometimes it describes a pure cribriform carcinoma, where most or all of the cancer shows the pattern. Sometimes it appears as a feature alongside other patterns — a report may say an invasive ductal carcinoma has cribriform areas, meaning part of the tumour shows that sieve-like arrangement. If you are unsure which applies to you, ask your doctor to point to the exact wording on your report.
What Makes It a “Special Type”
Breast cancers are grouped into types based on how they look and grow. The common types, such as invasive ductal carcinoma, are called “no special type” precisely because they are the familiar baseline. “Special types” are the less common cancers that form recognisable patterns of their own — tubular, mucinous, cribriform, and several others.
Cribriform is among the rarer of these. It is usually described as low-grade: the cells tend to look relatively orderly and close to normal under the microscope. Grade is a measure of how unusual the cells look, and lower grades generally mean the cells look calmer. But grade is only one ingredient in treatment decisions, and a low-grade finding does not by itself settle what treatment is right.
Rarity itself is worth a thought. Because few cases occur, much of what doctors know about cribriform comes from small case series and general experience with low-grade special types rather than from large trials devoted to it. That is not a reason for alarm — it is a reason to ask your care team how they are applying their knowledge to your case.
How It Is Diagnosed
The diagnostic path is the same as for other breast cancers. A change is found — by screening, by examination, or by symptoms — then imaging and a biopsy follow. The diagnosis of cribriform specifically is made by the pathologist examining the biopsy tissue under the microscope, where the sieve-like pattern is visible.
Pathologists may also run tests on the tissue that matter for treatment planning, such as hormone receptor and HER2 testing. These results shape the conversation about treatment just as they do for other types, and they are independent of the cribriform label.
Because the pattern can be a matter of interpretation — deciding how much of the tumour qualifies, or distinguishing pure cribriform from a mixed pattern — a second opinion on the pathology is something some patients choose. Asking for one is a normal part of breast cancer care and does not offend pathologists; it is how medicine checks its own work. Our guide to the complete diagnostic process explains each step in plain language.
Cribriform Compared With Common Types
Placing cribriform beside the familiar types helps show where the differences are and where they are not:
| Feature | Invasive ductal carcinoma (no special type) | Cribriform carcinoma |
|---|---|---|
| How common | The most common type by far | Rare special type |
| Typical grade | Varies widely | Usually low-grade |
| How it is found | Screening or symptoms, then biopsy | The same — screening or symptoms, then biopsy |
| How the name is given | Default category when no special pattern dominates | Named for the sieve-like cell pattern |
| Treatment planning | Based on size, grade, spread, receptors, patient factors | Based on the same full set of factors |
The last row is the one that matters most. Treatment is never planned from the type name alone — not for common types and not for rare ones. Size, grade, lymph node involvement, receptor results, age, health, and personal preferences all feed into the plan. Articles comparing other special types, such as invasive ductal versus invasive lobular carcinoma and invasive micropapillary breast cancer, follow the same principle.
How Care Teams Approach It
For any early invasive breast cancer, the broad shape of treatment usually involves surgery, possibly radiation, and sometimes medicines that work throughout the body. Where cribriform fits into that shape depends on the individual case, and the conversation with your care team is where it gets worked out.
What you can generally expect is that the team will treat the whole of your findings, not the label. A small, low-grade cribriform cancer may be approached much like any small, low-grade cancer; a larger one, or one with other concerning features, is handled on the basis of those features. The rarity of the type means the evidence the team leans on may be thinner than for common types, which is exactly why asking how they are weighing it is useful.
Be wary of anyone — a friend, a forum, a forwarded post — who tells you what a rare type “always” means for treatment. Individual cases differ too much for that. Your own doctor’s reading of your full pathology report is the version that applies to you.
Questions to Ask Your Doctor
- Is my cancer purely cribriform, or does it have cribriform areas alongside another pattern?
- How are you using this finding in my treatment plan — does it change anything compared with the usual approach?
- What were the grade, size, and lymph node results, and what do those mean together?
- What did the hormone receptor and HER2 testing show?
- Would a second opinion on my pathology be useful in my case?
- Where can I read reliable information about this type — cancer.org or cancer.gov?
Frequently Asked Questions
Is cribriform breast cancer a less serious kind of breast cancer?
It is usually described as low-grade, which means the cells look relatively orderly under the microscope. But “how serious” an individual cancer is depends on size, spread, and the full set of findings — not on the type name alone. Only your care team, reading your complete report, can characterise your case.
How common is it?
It is considered a rare special type of invasive breast cancer. For current figures, which are studied and updated over time, the American Cancer Society (cancer.org) and the National Cancer Institute (cancer.gov) are the sources to check.
Will my treatment be different because it is cribriform?
It might or might not be. Treatment is planned from the whole picture — size, grade, lymph node findings, receptor results, and your individual situation — not from the type name alone. Ask your care team how they are weighing this finding in your plan.
Can it be found on a mammogram like other breast cancers?
Yes — the path to diagnosis is the same. Screening finds a change, imaging and biopsy follow, and the pathologist identifies the pattern under the microscope. How the cancer was discovered does not depend on its special type.
Should I get a second opinion?
For a rare finding, some patients find a pathology second opinion reassuring, and requesting one is normal practice. Your doctor can advise whether it would change anything in your case.
Related Articles
- Types of Breast Cancer Compared: The Complete Guide
- Invasive Ductal vs Invasive Lobular Carcinoma: The Key Differences
- DCIS vs Invasive Ductal Carcinoma: What Changes When Cancer Is No Longer In Situ
- Invasive Micropapillary Breast Cancer Explained
This article is for general educational purposes only and is not medical, legal, or financial advice. It does not replace professional care. Talk to your doctor or care team about your own situation. If you think you may have a medical emergency, call 911.